The CoaguChek® XS System works for you
Test at home or virtually anywhere with the meter that's the top choice of doctors and their patients who require warfarin monitoring. The CoaguChek XS meter uses the same technology that's used in most physician offices. In fact, more INR tests are performed with a CoaguChek system than all other INR meters combined.1,6
Count on comfort and convenience:
Easy to use. The meter features two-button operation, automatic power-on and a large, easy-to-read display. Just one drop of blood is applied to the test strip to measure clotting time.
Minimal pain. A specially designed lancing device pricks the skin with a fine needle, or lancet, to obtain a blood sample for testing.
Fast results. Get your INR results in about a minute.
Lightweight and portable. Use at home or when you’re out and about.
Expert training and support. A professional trainer will teach you how to use the device, and there’s 24/7 customer support whenever you need it.
Live Technical Support
Get accurate, consistent results:
Consistent. The CoaguChek XS system has a 97 percent correlation to a laboratory3 and it provides consistent results, whether it’s used for self-testing or operated by a healthcare professional.2
CoaguChek technology reduces heparin interference for more accurate results.3
Never pre-owned. At Roche, we believe that each meter should be used by one, and only one, person. You can be confident that your CoaguChek XS meter from Roche is factory-new.
Coverage by Medicare and most insurance plans:
Medicare coverage – For many patients on long-term warfarin therapy, the CoaguChek XS system, training and supplies may be covered by Medicare Part B and private insurance.4,5 (Coverage varies based on your condition and other factors.)
Private insurance – Most private insurance companies also cover PT/INR self-testing (coverage varies based on your condition and other factors). Should you and your doctor decide that you should begin home monitoring with the CoaguChek XS system, CoaguChek Patient Services will work with your insurance carrier to confirm coverage.
Note: If you have a mechanical heart valve, chronic atrial fibrillation or venous thromboembolism, and you’re on long-term warfarin therapy, Medicare Part B may cover meter training, services, equipment and supplies for monitoring your INR at home with a portable handheld meter.4,5
1 Year-end 2012 data as reported in second quarter 2013, total dollar volume and share of projected distributor unit sales of the Coagulation Reagents/Kits, POC (91994) by GHX Market Intelligence Data. Total Market includes all market sectors as defined by GHX MI. Physician, LTC, Treatment Centers, Clinical Laboratory, Hospital, Home Healthcare and Other/Unspecified. Data on file at Roche Diagnostics.
2 Roche Diagnostics. Indianapolis, Ind. (2016). CoaguChek XS PT Test [package insert 05967694001(05)]. 97% correlation with lab results using Dade Innovin reagent. See package insert for more information.
3 The CoaguChek XS PT test strip neutralizes heparin (up to 0.8 U/mL) and LMWh (up to 2.0 U/ML) as long as the INR is below 2.9.
4 Medicare Part B provides coverage for use of home PT/INR monitoring for chronic, oral anticoagulation management for patients with mechanical heart valves, chronic atrial fibrillation or venous thromboembolism (inclusive of deep venous thrombosis and pulmonary embolism) on warfarin. The monitor and the home testing must be prescribed by a treating physician, and other requirements must also be met to qualify for coverage. Under private insurance, coverage varies by plan. Consult your health insurance provider for details regarding coverage.
5 Centers for Medicare and Medicaid Services. National Coverage Determination (NCD) for Home Prothrombin Time/International Normalized Ratio (PT/INR) Monitoring for Anticoagulation Management (190.11), http://www.cms.gov/medicare-coverage-database/details/ ncd-details.aspx?NCDId=269&ver=2. (accessed January 2018).
6 Internet availability required for wireless reporting. 2net (TM) Hub transmitter works only in the United States and requires a reliable cellular connection